The Masked Manic: Why Bipolar Disorder Is Often Missed as Depression

Contributors

Dr. Narayanan Mooss

Ayurvedic Psychiatrist

Ms. Muktha

Clinical Psychologist

Key Take Aways

Bipolar disorder affects millions worldwide but is frequently misdiagnosed often as major depression because depressive episodes resemble unipolar depression while manic or hypomanic phases may be brief, overlooked, or perceived as simply feeling good. This diagnostic delay, especially in Bipolar II, can lead to inappropriate antidepressant treatment, delayed access to mood stabilisers, and a significantly higher suicide risk. Accurate diagnosis depends on exploring a person’s full mood history, particularly periods of unusual elevation or increased energy. Ayurveda views bipolar disorder through the lens of Unmada and imbalance in Vata, Pitta, and Kapha, supporting stability through grounding routines, Medhya Rasayana herbs like Ashwagandha and Brahmi, Shirodhara, and calming diets alongside medical treatment. Yoga, mindfulness, MBCT, pranayama, and restorative practices can further support emotional regulation and nervous system balance, but recognising the condition correctly remains the most important step in transforming long-term outcomes.

Full Article

Unmasking the disorder that hides behind the blues.

For instance, you might wonder:

All of these questions are normal and it’s understandable that you want to support your loved one to the best of your ability

While your questions are valid, it’s also important to understand that every person’s experience with depression is unique, so there are a few things you can do to help your loved one and yourself.

Introduction: The Bipolar Chameleon

Picture a chameleon on a blue-grey wall. It does not announce itself. It does not stand out. It simply blends in, looking exactly like the background it sits against. Bipolar disorder does the same thing — except the background it blends into is depression, and the consequences of that invisibility can be severe and lasting.

Bipolar disorder, formerly called manic-depressive illness, is a chronic brain condition that causes significant and recurring shifts in mood, energy, concentration, and the capacity to function from one day to the next. According to NIMH, it affects an estimated 2.8% of US adults, and the WHO includes it among the twelve leading causes of disability worldwide. Yet for all its prevalence and impact, it is routinely missed — not because clinicians are careless, but because the disorder is genuinely designed by its own nature to look like something else.

Most people with bipolar disorder first seek help when they are depressed. They arrive at a clinic or a GP’s office feeling low, exhausted, hopeless, and unable to function. They do not arrive describing episodes of elevated mood, racing thoughts, or the impulsive decisions that accompany mania or hypomania — either because those episodes haven’t happened yet, happened briefly and seemed unremarkable, or are simply not something a person in crisis thinks to mention. The result is a diagnosis of depression, a prescription for antidepressants, and often years of treatment that doesn’t quite work.

This article is about understanding why that happens, what it costs, and how a more complete picture changes everything.

"Mental health is not a destination, but a process. It's about how you drive, not where you're going."

The Depressive Disguise: How Bipolar Mimics Unipolar Depression

The depressive phase of bipolar disorder and a standalone major depressive episode (MDD, also called unipolar depression) look, from the outside, almost identical. The symptoms overlap so comprehensively that even experienced clinicians can and do mistake one for the other — especially at first presentation, when there is no history to distinguish between them.

Both bipolar depression and unipolar depression involve:

Persistent low mood, sadness, or a pervasive sense of emptiness and hopelessness.
Loss of interest or pleasure in activities that previously brought enjoyment.
Fatigue, physical heaviness, and dramatically reduced energy.
Difficulty concentrating, making decisions, or retaining information.
Significant changes in appetite -- eating far less or far more than usual.
Significant changes in appetite -- eating far less or far more than usual.
Thoughts of death, dying, or suicide.

The critical difference is not in the depression itself — it’s in what precedes or follows it. Bipolar disorder is defined by the presence of manic or hypomanic episodes: distinct periods of abnormally elevated, expansive, or irritable mood and increased energy that are markedly different from the person’s baseline. In Bipolar I, at least one full manic episode is required for diagnosis. In Bipolar II, the elevated episodes are hypomanic — less intense, shorter in duration, and not causing the severe functional disruption of full mania — but still clinically significant.

The catch is this: up to 70% of people with bipolar disorder experience a depressive episode first, before any manic or hypomanic episode occurs. And in some cases, manic symptoms may not emerge until twenty years after the initial depressive episode. If no one is specifically asking about elevated mood, increased energy, reduced need for sleep, or uncharacteristic impulsivity — and most standard depression assessments don’t — the bipolar component stays invisible.

Key distinction: People with bipolar disorder can have normal body weight, hold jobs, and appear high-functioning during depressive phases. The disorder does not present with obvious ‘warning signs’ that something unusual is happening. That is precisely what makes it so easy to miss.

Why the Misdiagnosis Happens: A Perfect Storm

Misdiagnosis of bipolar disorder is not an occasional anomaly — it is the norm. A large survey by the National Depressive and Manic-Depressive Association found that 73% of patients with bipolar disorder were misdiagnosed on initial presentation to a healthcare professional. The most frequent misdiagnosis was depression. Research consistently shows that bipolar disorder may go unrecognised for 7 to 10 years, with many patients receiving three or more professional evaluations before a correct diagnosis. Several interconnected factors drive this.

The Spotlight Effect on Depression

Depression is the most commonly recognised and discussed mental health condition in the world. It has the most public awareness, the most standardised screening tools, and the most front-of-mind clinical recognition. When someone walks into a consulting room reporting low mood, exhaustion, and hopelessness, the cognitive pull toward a depression diagnosis is significant and understandable. Bipolar disorder simply gets less air time in clinical training, public discourse, and routine screening — which means it gets considered less often, particularly in presentations where depressive features dominate.

Brief or Absent Manic Episodes -- and the Hypomania Problem

Full manic episodes are dramatic and hard to miss: days of little or no sleep while feeling energised, racing thoughts, pressured speech, grandiosity, and often impulsive or risky behaviour severe enough to cause significant real-world consequences. People in full mania generally end up in hospital.

Hypomanic episodes are something else entirely. They are shorter (minimum four days), less severe, and definitionally do not cause marked impairment in social or occupational functioning. During a hypomanic episode, a person may feel unusually energetic, creative, confident, and productive. Their thinking is faster, their social inhibitions lower, their need for sleep reduced. To the person experiencing it, this may not feel like an episode of illness — it may feel like finally being at their best. Research confirms that both patients and clinicians consistently fail to recognise hypomania reliably. Patients may actively enjoy the elevated state and have no motivation to report it. Clinicians may not ask about it specifically, or may interpret descriptions of it as periods of normal functioning or recovery from depression.

This is the core vulnerability for Bipolar II misdiagnosis. Because the disorder’s elevated pole never reaches the severity of full mania, and the depressive episodes are functionally identical to major depression, it can go entirely undetected for more than a decade. Research shows it takes on average 12 years before patients seeking mental health services are appropriately diagnosed with Bipolar II — compared to 7 years for Bipolar I.

Inadequate Screening for the Full Mood History

The standard clinical workflow for someone presenting with low mood typically focuses on characterising the depressive symptoms: their nature, duration, severity, and associated features. What is less frequently done is a systematic and detailed inquiry into the person’s mood history beyond the current episode — specifically asking about any past periods of elevated energy, reduced sleep without fatigue, increased confidence or talkativeness, spending or sexual behaviour that was out of character, or decisions that seemed good at the time but were later regretted.

Without that inquiry, the hypomanic history stays buried. There are validated screening instruments — most notably the Mood Disorder Questionnaire (MDQ), a self-report tool covering 13 symptom domains — that can flag patients most likely to have bipolar spectrum disorder and prompt more thorough evaluation. But these are not universally deployed in primary care or general mental health settings, where most bipolar disorder is first encountered.

Additionally, lack of patient insight is a characteristic feature of the elevated phases of bipolar disorder. During mania or hypomania, the person often has limited awareness that their mood and behaviour are elevated from their baseline. This means that even when clinicians ask, the information they receive may be incomplete or normalised by the patient themselves. Collateral history from family members or close friends can be invaluable — and is often not collected as standard.

The Consequences of Misdiagnosis: A Ripple Effect

Getting the diagnosis wrong does not mean treatment fails to happen — it means the wrong treatment happens, and the consequences stack up over time in ways that compound the burden of the illness significantly.

Ineffective and potentially harmful treatment: Antidepressants prescribed for what is believed to be unipolar depression can, in bipolar disorder, trigger the very events they are meant to prevent. A study of bipolar patients previously diagnosed with unipolar depression found that 55% developed mania and 23% became rapid cyclers after antidepressant treatment. Rapid cycling -- four or more mood episodes in a twelve-month period -- is associated with worse long-term outcomes, higher rates of depression, more treatment resistance, and a higher risk of suicide. This is not a rare side effect in a small population. In a study of 51 patients with rapid cycling bipolar disorder, antidepressant use was associated with the continuation of cycling in 51% of cases. Antidepressants are not harmless in the wrong context; in bipolar disorder, they can actively destabilise the illness.
Delayed access to the right care: The right treatments for bipolar disorder are fundamentally different from those for unipolar depression. Mood stabilisers -- lithium, valproate, lamotrigine, and certain atypical antipsychotics -- are the cornerstone of bipolar management. Lithium alone, the gold standard for Bipolar I, reduces time spent in manic or hypomanic states by 61% and time in depression by 53%. It is the only mood stabiliser shown to reduce suicide rates in bipolar disorder. None of these agents are typically deployed while the diagnosis remains depression. Every year spent in misdiagnosis is a year without access to treatments with this level of evidence.
Prolonged suffering and real-world damage: Living with misdiagnosed bipolar disorder typically means living with increasingly treatment-resistant 'depression,' a growing sense that something is fundamentally wrong that no one can identify, and the progressive damage of unmanaged mood episodes on relationships, careers, finances, and self-concept. The lifetime risk of suicide attempts in people with bipolar disorder is 25 to 50% -- compared to 15% in unipolar depression. The majority of suicides in bipolar disorder occur during depressive phases, not manic ones. Delay in correct diagnosis is directly correlated with increased rates of suicide attempts and higher long-term healthcare costs. At least one major life domain (work, social relationships, or family life) is significantly impaired in 52-54% of people with bipolar disorder.

Eastern Wisdom: An Ayurvedic and Yogic Perspective

Traditional Eastern medicine approaches mental health from a fundamentally different starting point: not as a brain malfunction to be corrected, but as a disruption of the dynamic balance between interconnected systems of mind, body, and spirit. This does not replace Western clinical treatment for bipolar disorder — which requires medical management and should never be discontinued without a clinician’s guidance — but it offers a complementary framework and practices that many people find meaningful alongside standard care.

Ayurveda and the Doshas

In Ayurvedic understanding, bipolar disorder is framed through the classical concept of Unmada — a broad term for disorders of the mind that disrupt perception, judgment, memory, and behavioural control. The three primary dosha expressions of Unmada map closely onto the phases of bipolar disorder:

Vataja Unmada (Vata-driven mental imbalance) corresponds to the manic and mixed phases: the racing thoughts, erratic behaviour, pressured speech, inability to focus, rapid shifting between ideas, and the profound restlessness and instability of mania. Vata, as the dosha of movement and air, governs the nervous system and all movement in the mind and body. When severely aggravated, it produces exactly the mental volatility and unpredictability that characterises mania. A peer-reviewed PMC study by Mills et al. confirmed that Vata imbalance is significantly associated with more anxiety, more rumination, and less mindfulness (all p ≤ 0.05) -- the psychological profile that maps onto the elevated phase's neurological hyperactivation.
Pittaja Unmada (Pitta-driven mental imbalance) adds the anger, irritability, intense self-criticism, aggressiveness, and emotional volatility that mark the mixed states and irritable mania common in bipolar disorder. Pitta governs heat, intensity, and metabolism. When excessive, it produces a mind that burns with frustration and self-reproach -- the internally directed fire that characterises the darker, more destructive face of elevated mood episodes.
Kaphaja Unmada (Kapha-driven mental imbalance) corresponds to the depressive phase: the heaviness, lethargy, withdrawal, hypersomnia, hopelessness, and loss of motivation that characterise bipolar depression. Kapha governs structure, stability, and slowness. When it dominates the mind pathologically, it produces exactly the low-energy, inward-collapsing quality of depression.

The Ayurvedic framework also introduces the concept of the three Mahagunas — the fundamental mental qualities of Sattva (clarity, equanimity, discernment), Rajas (agitation, passion, turbulence), and Tamas (inertia, dullness, darkness) — which map directly onto the oscillation between manic and depressive states. Mania corresponds to excessive Rajas: the mind is overactivated, restless, pleasure-seeking, and unable to still. Depression corresponds to excessive Tamas: the mind is withdrawn, stuck, inert, and without motivation. The goal of Ayurvedic mental practice is to increase Sattva — the quality of calm clarity — as the counterbalance to both extremes.

Ayurvedic interventions for bipolar disorder, always practiced under qualified guidance and alongside (never replacing) Western medical management, include:

Dinacharya (daily routine): The single most important Vata-calming intervention. Fixed sleep, wake, and meal times create the neurological predictability that directly reduces Vata's contribution to mood instability. Research on bipolar disorder consistently identifies disrupted circadian rhythms and irregular social rhythms as key triggers for mood episodes -- making the Ayurvedic emphasis on structured routine directly relevant.
Shirodhara: A therapeutic procedure in which a steady stream of warm medicated oil is gently poured over the forehead. Deeply calming for an overactive nervous system, Shirodhara has documented effects on reducing anxiety, cortisol, and sympathetic nervous system activation. It is particularly used in Ayurveda for Vata-driven mental disturbance.
Medhya Rasayanas (brain-nourishing herbs): Ashwagandha (Withania somnifera) as an adaptogen for anxiety, stress, and nervous system dysregulation -- supported by a PMC RCT showing significant reductions in perceived stress and cortisol. Brahmi (Bacopa monnieri) for cognitive clarity and nervous system calming. Jatamansi (Nardostachys jatamansi) for its specific calming action on the nervous system, particularly in Vata-driven restlessness. Shankhapushpi (Convolvulus pluricaulis) for emotional stabilisation and mental clarity.
Diet: Vata-pacifying foods -- warm, grounding, sweet, salty, and sour tastes; cooked grains; healthy fats like ghee and sesame oil -- provide the physical counterbalance to Vata's dry, cold, and erratic qualities. Avoiding stimulants (caffeine, alcohol, refined sugar) and highly processed foods reduces neurological volatility.

Yoga for Bipolar: Balancing the Energies

Yoga’s relevance to bipolar disorder is best understood through its effects on the autonomic nervous system, emotional regulation, and interoceptive awareness — the capacity to sense and read internal body and mood states. These are precisely the faculties that are disrupted in bipolar disorder.

A 2023 PMC systematic review on evidence-based psychotherapies for bipolar disorder identified Mindfulness-Based Cognitive Therapy (MBCT) — which integrates formal mindfulness meditation and movement — as a promising intervention with encouraging findings across three RCTs. A 2023 multicentre RCT published in PMC (144 participants with Bipolar I and II) found that MBCT added to treatment as usual produced improvements in psychosocial functioning, with participants who had higher baseline depressive symptoms benefitting most. Across MBCT studies in bipolar disorder, consistent improvements have been found in residual depressive symptoms, attentional difficulties, emotional regulation, psychological wellbeing, and mindfulness itself.

Specific yoga practices particularly relevant for bipolar disorder:

Pranayama (Breathwork): Nadi Shodhana (alternate nostril breathing) directly regulates the autonomic nervous system and has been shown to significantly improve heart rate variability -- a measure of the nervous system's capacity for flexible self-regulation. It is particularly useful during periods of elevated energy or anxiety as an accessible, portable intervention. Bhramari (humming bee breath) rapidly activates the parasympathetic nervous system through the vagus nerve, reducing the emotional intensity of agitated states. Sama Vritti (equal-ratio breathing) builds present-moment focus and interrupts ruminative thought loops in both depressive and elevated states.
Grounding asanas (postures): Tadasana (mountain pose) and Virabhadrasana (warrior series) build a felt sense of physical stability, groundedness, and structural strength -- directly counteracting the untethered quality of manic states. Balasana (child's pose) and supported restorative postures activate parasympathetic calming and provide the physical experience of safety and stillness during elevated or anxious phases.
Mindfulness meditation: The capacity to observe one's own mental states with non-judgmental awareness -- which is specifically trained in mindfulness practice -- is exactly what people with bipolar disorder most need to develop. Being able to notice the early signs of mood elevation or deepening depression, from a position of some internal distance rather than being swept into them, enables earlier intervention and greater agency. MBCT studies in bipolar populations document improvements in the capacity to detect mood changes more quickly and feel less overwhelmed by them.

Important Note: Yoga and Ayurvedic practices should always be introduced gradually, under the guidance of qualified practitioners familiar with bipolar disorder, and never as replacements for pharmacotherapy or clinical psychiatric care. Stimulating practices (vigorous pranayama, dynamic sequences, extended heated yoga) should be approached with particular caution during elevated phases.

Unveiling the Full Picture: Accurate Diagnosis Matters

The path to an accurate bipolar diagnosis runs through the same place most missed diagnoses do: a clinical conversation that is comprehensive enough to surface what a standard assessment misses. This is not about clinicians being more diligent in some vague sense — it is about specific things being done that are frequently not done.

A thorough psychiatric evaluation for anyone presenting with depression should include:

A full personal and family psychiatric history. Not just the current episode -- the entire longitudinal mood history. Key questions: Have there ever been periods, even brief ones, of feeling unusually energised or needing less sleep? Were there times of unusual confidence, talkativeness, spending, or impulsivity that were out of character? Is there a family history of bipolar disorder, mania, or mood instability? The family history question matters because bipolar disorder has significant heritable components -- genetics contribute substantially, though environmental factors and life experience also play critical roles.
Careful assessment of both poles of the mood spectrum -- not just the presenting depression. This means explicitly asking about past and current elevated mood states, not waiting for the patient to volunteer them.
Use of a validated screening instrument such as the Mood Disorder Questionnaire (MDQ). The MDQ is a brief, self-report tool covering 13 symptom clusters that has been validated to identify patients most likely to have bipolar spectrum disorder. It does not make the diagnosis -- a full clinical evaluation does -- but it flags the patients who need one. Studies show it significantly improves the chances of timely, accurate diagnosis.
Collateral information from family members or close friends where the patient consents. People who live with someone with bipolar disorder often observe the elevated phases more clearly than the person experiencing them -- and this information can be decisive in establishing the presence of hypomania that the patient may not have recognised as abnormal.
Differential diagnosis work: ruling out medical conditions that can mimic mood episodes (thyroid disorders, neurological conditions), substance use, and conditions that overlap phenomenologically with bipolar disorder -- particularly ADHD, borderline personality disorder, and cyclothymia.

A Personal Note: Sarah's Story

Sarah had been fighting what everyone — including her — believed was treatment-resistant depression for seven years. Seven years of trying antidepressants: SSRIs, SNRIs, combinations, augmentations. Some of them helped for a while before stopping. Most of them didn’t help much at all. A few made her feel, she said, ‘like I was running too fast but couldn’t stop.’ She assumed that was just her anxiety.

What nobody had asked her — not in seven years of appointments — was about the good periods. Not the recovery-from-depression periods, but the other ones. The weeks where she barely needed to sleep but felt sharper and more capable than usual. The projects she launched at 2am with complete certainty they were brilliant. The times she talked too fast and couldn’t always follow her own train of thought but didn’t mind because it all felt connected and alive. She had never thought to mention these. They felt like proof that she was sometimes okay. Why would she report feeling okay?

It was a new therapist who finally asked the right questions — specifically, carefully, without leading. She walked Sarah through the elevated periods with a level of clinical precision Sarah hadn’t encountered before. When had they happened? How long did they last? Did she sleep less during them? Did other people notice a change? What happened after?

The picture that emerged was a Bipolar II profile that had been sitting in plain sight for years. The ‘running too fast’ feeling on antidepressants was a hypomanic switch. The treatment resistance wasn’t because her depression was uniquely stubborn — it was because antidepressants, without a mood stabiliser, were repeatedly destabilising the very condition they were meant to treat.

A revised diagnosis. A mood stabiliser added to her treatment. The difference, Sarah says, was not dramatic in the way she might have imagined — there was no single turning point, no sudden resolution. It was more like the ground stopped moving. Episodes still happened, but they were shorter and less severe, and she had enough forewarning to use the tools she’d been building in therapy. She knew, now, what she was working with.

She still has bipolar disorder. She expects to manage it for the rest of her life. But managing a correctly diagnosed condition is categorically different from failing to treat a misidentified one — and that difference, she says, is everything.

FAQs:

Q: Can bipolar disorder be cured?

Ans. Bipolar disorder is a chronic, lifelong condition — it does not resolve the way an infection does. However, ‘chronic’ and ‘unmanageable’ are not the same thing. With accurate diagnosis and the right combination of pharmacotherapy (mood stabilisers, and sometimes atypical antipsychotics or adjunctive medications), evidence-based psychotherapy (particularly psychoeducation, CBT, interpersonal and social rhythm therapy, and family-focused therapy), and lifestyle management, the majority of people with bipolar disorder achieve meaningful stability and lead full, productive lives. The operative word is accurate: treatment that is correctly targeted to bipolar disorder, rather than unipolar depression, produces fundamentally different outcomes.

Q: Is bipolar disorder genetic?

Ans. Genetics play a significant role — bipolar disorder has among the highest heritability of any psychiatric condition, with twin studies estimating heritability at around 70-80%. Having a first-degree relative with bipolar disorder substantially elevates risk. However, heritability does not mean determinism. Environmental factors, early life stress, trauma, substance use, and major life disruptions all contribute to whether, when, and how severely the disorder emerges. A genetic predisposition creates vulnerability; it does not guarantee the outcome. This matters both for understanding the condition and for risk screening of family members.

Q: What's the difference between Bipolar I and Bipolar II?

Ans. Bipolar I requires at least one full manic episode — a distinct period of abnormally elevated or irritable mood and increased energy lasting at least seven days (or any duration if hospitalisation is required), severe enough to cause marked functional impairment or to involve psychotic features. Bipolar I manic episodes are not subtle. Bipolar II requires at least one hypomanic episode (minimum four days, elevated or irritable mood and energy, but without the severe impairment or psychosis of mania) and at least one major depressive episode. Critically: a Bipolar II diagnosis requires the confirmed absence of any full manic episode. If mania occurs, the diagnosis converts to Bipolar I. Bipolar II is often misconceived as a milder form of bipolar disorder — but research shows it may be more debilitating overall than Bipolar I because chronic depression is more prominent and the hypomanic episodes are harder to identify and treat.

Q: What happens if bipolar disorder is treated with antidepressants alone?

Ans. Antidepressants used as monotherapy in bipolar disorder carry significant risks. They can trigger manic or hypomanic episodes in people who have not yet experienced one, effectively accelerating the illness course. In people already diagnosed with bipolar disorder, antidepressant monotherapy can induce rapid cycling (four or more mood episodes per year), which is associated with greater chronicity, more treatment resistance, and worse long-term outcomes. Current guidelines from CANMAT/ISBD and NICE explicitly state that antidepressants should not be used as monotherapy in most patients with bipolar disorder, and that when they are used, they should be combined with a mood stabiliser or atypical antipsychotic. This is the central clinical argument for why accurate diagnosis matters: it determines whether someone receives antidepressants alone, or mood stabilisers with appropriate adjunctive care.

Q: How is bipolar disorder actually treated once correctly diagnosed?

Ans. Pharmacotherapy is the foundation. Lithium remains the gold standard for Bipolar I — reducing time in elevated states by 61%, time in depression by 53%, and uniquely among mood stabilisers, demonstrably reducing suicide rates. Valproate (Depakote) is particularly effective for rapid-cycling and mixed-state presentations. Lamotrigine (Lamictal) is especially effective for the depressive pole. Atypical antipsychotics (quetiapine, aripiprazole, olanzapine, lurasidone) are used across acute phases and maintenance. For Bipolar II depression specifically, quetiapine is the only recommended first-line agent according to CANMAT/ISBD 2023 guidelines. Psychotherapy — particularly psychoeducation, CBT, interpersonal and social rhythm therapy (IPSRT), and family-focused therapy (FFT) — has strong RCT evidence as an adjunct to pharmacotherapy. Lifestyle management: consistent sleep-wake cycles, avoidance of alcohol and stimulants, and regular routine are not optional lifestyle choices — they are active components of relapse prevention.

Conclusion

Bipolar disorder is a condition that lives on a spectrum — not just in terms of its severity and presentation, but in terms of how long it takes to be seen for what it actually is. For the millions of people living with an unrecognised version of it, the spectrum they inhabit is one defined by the wrong treatment, the wrong story about themselves, and the compounding damage of years without appropriate support.

Understanding that bipolar disorder routinely masquerades as depression is not an abstract psychiatric footnote. It is information that has the potential to change outcomes in real lives. For clinicians, it is an argument for systematic screening and thorough mood histories. For people who have not responded well to depression treatment, it is an argument for asking more questions and not accepting ‘treatment-resistant depression’ as a final answer without further investigation. For family members watching someone they love struggle, it is a reason to share what they observe.

The good news is unambiguous: once correctly identified, bipolar disorder is a condition that responds to treatment. Lithium, the mood stabilisers, the evidence-based psychotherapies, the Ayurvedic and yogic practices that support the mind-body system alongside clinical care — all of these are available. The prerequisite is the right diagnosis. And the prerequisite for that is the right conversation.

Let’s keep having it.

Spectrum

Relationships

Navigating Life

About Us